148 related articles for article (PubMed ID: 31506954)
1. Exogenous hormone use and cutaneous melanoma risk in women: The European Prospective Investigation into Cancer and Nutrition.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Fournier A; Boutron-Ruault MC; Severi G; Caini S; Palli D; Ghiasvand R; Veierod MB; Botteri E; Tjønneland A; Olsen A; Fortner RT; Kaaks R; Schulze MB; Panico S; Trichopoulou A; Dessinioti C; Niforou K; Sieri S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Sandanger TM; Colorado-Yohar S; Sánchez MJ; Gil Majuelo L; Lujan-Barroso L; Ardanaz E; Merino S; Isaksson K; Butt S; Ljuslinder I; Jansson M; Travis RC; Khaw KT; Weiderpass E; Dossus L; Rinaldi S; Kvaskoff M
Int J Cancer; 2020 Jun; 146(12):3267-3280. PubMed ID: 31506954
[TBL] [Abstract][Full Text] [Related]
2. Citrus intake and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC).
Mahamat-Saleh Y; Cervenka I; Al-Rahmoun M; Mancini FR; Severi G; Ghiasvand R; Veierod MB; Caini S; Palli D; Botteri E; Sacerdote C; Ricceri F; Trichopoulou A; Peppa E; La Vecchia C; Overvad K; Dahm CC; Olsen A; Tjønneland A; Perez-Cornago A; Jakszyn P; Grioni S; Schulze MB; Skeie G; Lasheras C; Colorado-Yohar S; Rodríguez-Barranco M; Kühn T; Katzke VA; Amiano P; Tumino R; Panico S; Ezponda A; Sonestedt E; Scalbert A; Weiderpass E; Boutron-Ruault MC; Kvaskoff M
Eur J Epidemiol; 2020 Nov; 35(11):1057-1067. PubMed ID: 32710289
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
[TBL] [Abstract][Full Text] [Related]
4. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
Tang JY; Spaunhurst KM; Chlebowski RT; Wactawski-Wende J; Keiser E; Thomas F; Anderson ML; Zeitouni NC; Larson JC; Stefanick ML
J Natl Cancer Inst; 2011 Oct; 103(19):1469-75. PubMed ID: 21878677
[TBL] [Abstract][Full Text] [Related]
5. Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists.
Mai JZ; Zhang R; Sargen MR; Little MP; Alexander BH; Tucker MA; Kitahara CM; Cahoon EK
Hum Reprod; 2022 May; 37(5):1059-1068. PubMed ID: 35174864
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and reproductive factors in melanoma risk.
Osterlind A
Clin Dermatol; 1992; 10(1):75-8. PubMed ID: 1504931
[TBL] [Abstract][Full Text] [Related]
7. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study.
Zamora-Ros R; Rinaldi S; Biessy C; Tjønneland A; Halkjaer J; Fournier A; Boutron-Ruault MC; Mesrine S; Tikk K; Fortner RT; Boeing H; Förster J; Trichopoulou A; Trichopoulos D; Papatesta EM; Masala G; Tagliabue G; Panico S; Tumino R; Polidoro S; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Lund E; Argüelles M; Agudo A; Molina-Montes E; Navarro C; Barricarte A; Larrañaga N; Manjer J; Almquist M; Sandström M; Hennings J; Tsilidis KK; Schmidt JA; Khaw KT; Wareham NJ; Romieu I; Byrnes G; Gunter MJ; Riboli E; Franceschi S
Int J Cancer; 2015 Mar; 136(5):1218-27. PubMed ID: 25041790
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and the risk of melanoma in post-menopausal women.
Hicks BM; Kristensen KB; Pedersen SA; Hölmich LR; Pottegård A
Hum Reprod; 2019 Dec; 34(12):2418-2429. PubMed ID: 31803923
[TBL] [Abstract][Full Text] [Related]
10. Reproductive factors, exogenous hormone use and incidence of melanoma among women in the United States.
Donley GM; Liu WT; Pfeiffer RM; McDonald EC; Peters KO; Tucker MA; Cahoon EK
Br J Cancer; 2019 Apr; 120(7):754-760. PubMed ID: 30814688
[TBL] [Abstract][Full Text] [Related]
11. Hormonal and reproductive influences and risk of melanoma in women.
Smith MA; Fine JA; Barnhill RL; Berwick M
Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
[TBL] [Abstract][Full Text] [Related]
12. Fertility drugs and cutaneous melanoma risk: a French prospective cohort study.
Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Boutron-Ruault MC; Fournier A; Kvaskoff M
Eur J Cancer Prev; 2020 Mar; 29(2):182-185. PubMed ID: 31764213
[TBL] [Abstract][Full Text] [Related]
13. Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC).
Mahamat-Saleh Y; Al-Rahmoun M; Severi G; Ghiasvand R; Veierod MB; Caini S; Palli D; Botteri E; Sacerdote C; Ricceri F; Lukic M; Sánchez MJ; Pala V; Tumino R; Chiodini P; Amiano P; Colorado-Yohar S; Chirlaque MD; Ardanaz E; Bonet C; Katzke V; Kaaks R; Schulze MB; Overvad K; Dahm CC; Antoniussen CS; Tjønneland A; Kyrø C; Bueno-de-Mesquita B; Manjer J; Jansson M; Esberg A; Mori N; Ferrari P; Weiderpass E; Boutron-Ruault MC; Kvaskoff M
Int J Cancer; 2023 Feb; 152(3):348-362. PubMed ID: 36053839
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study.
Cervenka I; Mahamat-Saleh Y; Savoye I; Dartois L; Boutron-Ruault MC; Fournier A; Kvaskoff M
Int J Cancer; 2018 Nov; 143(10):2390-2399. PubMed ID: 29978471
[TBL] [Abstract][Full Text] [Related]
15. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women.
Osterlind A; Tucker MA; Stone BJ; Jensen OM
Int J Cancer; 1988 Dec; 42(6):821-4. PubMed ID: 3192324
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors.
Holman CD; Armstrong BK; Heenan PJ
Br J Cancer; 1984 Nov; 50(5):673-80. PubMed ID: 6498065
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
[TBL] [Abstract][Full Text] [Related]
18. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
[TBL] [Abstract][Full Text] [Related]
19. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal exogenous hormone therapy and Melanoma risk in women: A systematic review and time-response meta-analysis.
Tang X; Zhang H; Cui Y; Wang L; Wang Z; Zhang Y; Huo J; Cai J; Rinaldi G; Bhagavathula AS; Xiaopeng Y
Pharmacol Res; 2020 Oct; 160():105182. PubMed ID: 32890740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
